Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2010
11/18/2010US20100292189 Oligonucleotide analog and method for treating flavivirus infections
11/18/2010US20100292171 Competitive Regulation of Hepcidin mRNA by Soluble and Cell-Associated Hemojuvelin
11/18/2010US20100292166 PHARMACEUTICAL COMPOSITION FOR TREATING MALIGNANT TUMORS CONTAINING HUMAN p31 GENES
11/18/2010US20100292161 Polypeptides and methods of use
11/18/2010US20100292160 Hla-a* 3303-restricted wt1 peptide and pharmaceutical composition comprising the same
11/18/2010US20100292151 Use of human cytokine receptor
11/18/2010US20100292142 Novel neurotrophic factors
11/18/2010US20100292137 Antibiotics and Methods For Producing Them
11/18/2010US20100292130 Biological active proteins having increased in vivo and/or in vitro stability
11/18/2010US20100292104 Photoswitchable Method for the Ordered Attachment of Proteins to Surfaces
11/18/2010US20100292103 Focused libraries of genetic packages
11/18/2010US20100292099 Targeting of rna with external guide sequences
11/18/2010US20100292091 Mara family helix-turn-helix domains and their methods of use
11/18/2010US20100291684 Mutagenesis method using polyethylene glycol mediated introduction of mutagenic nucleobases into plant protoplasts
11/18/2010US20100291683 Modified Antigen Presenting Cells and Methods of Use
11/18/2010US20100291682 System for transposing hyperactive recombinant derivatives of mos-1 transposon
11/18/2010US20100291681 Methods and compositions for selecting siRNA of improved functionality
11/18/2010US20100291680 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission
11/18/2010US20100291676 Humanized anti-cd4 antibody with immunosuppressive properties
11/18/2010US20100291673 Alternative export pathways for vector expressed rna interference
11/18/2010US20100291671 Modified Viral Vector Particles
11/18/2010US20100291657 Ribonucleases in which an amino acid sequence of a known ribonuclease is preceded by at least one residue at the n-terminus, and methods of making them recombinantly
11/18/2010US20100291655 Novel glucose dehydrogenase and method for producing the dehydrogenase
11/18/2010US20100291652 Yeast strains and methods of making and using such yeast strains
11/18/2010US20100291651 Recombinant hydrogen-producing cyanobacterium and uses thereof
11/18/2010US20100291648 Global transcription machinery engineering
11/18/2010US20100291647 Microorganisms Having Enhanced Resistance To Acetate And Related Compositions And Methods of Use
11/18/2010US20100291643 Method for producing enationmerically pure d-ppt
11/18/2010US20100291642 Process For Preparing Dipeptidyl Peptidase IV Inhibitors And Intermediates Therefor
11/18/2010US20100291633 Method of cloning at least one nucleic acid molecule of interest using type iis restriction endonucleases, and corresponding cloning vectors, kits and system using type iis restriction endonucleases
11/18/2010US20100291631 Novel Beta-Galactoside-Alpha 2,3-Sialyltransferase, a Gene Encoding Thereof, and a Method for Producing Thereof
11/18/2010US20100291628 Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost
11/18/2010US20100291627 Method for production of antibody
11/18/2010US20100291625 Regulation of translation of heterologously expressed genes
11/18/2010US20100291624 Compositions and methods for improved glycoprotein sialylation
11/18/2010US20100291616 Novel genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
11/18/2010US20100291586 Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications
11/18/2010US20100291580 Biomarkers for trichogenicity
11/18/2010US20100291579 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
11/18/2010US20100291570 Materials and methods for detection of nucleic acids
11/18/2010US20100291567 Genes and polypeptides relating to hepatocellular or colorectal carcinoma
11/18/2010US20100291557 Binary probe and clamp composition and methods for target hybridization detection
11/18/2010US20100291556 Isolated aebp1 genomic polynucleotide fragments from chomosome 7 and their uses
11/18/2010US20100291550 Methods and compositions for modulating hair growth
11/18/2010US20100291262 Lipolytic Enzyme Variants
11/18/2010US20100291194 Compositions and Methods for Inhibiting Expression of a Mutant Gene
11/18/2010US20100291153 Vaccines against bordetella pertussis based on lps glycosyltransferase mutants
11/18/2010US20100291150 Pseudomonas exotoxin a cd4+ t-cell epitopes
11/18/2010US20100291149 Attenuated listeria spp. and methods for using the same
11/18/2010US20100291147 Recombinant rsv antigens
11/18/2010US20100291144 Novel vaccines against multiple subtypes of dengue virus
11/18/2010US20100291143 Inhibition of HIV and SHIV Replication with Antisense Interleukin-4
11/18/2010US20100291142 Bacterial Artificial Chromosome Containing Feline Herpes Virus Type 1 Genome and Uses Thereof
11/18/2010US20100291141 Truncated l1 protein of human papillomavirus type 11
11/18/2010US20100291140 Antibiotic resistance free listeria strains and methods for constructing and using same
11/18/2010US20100291139 Recombinant mva virus and the use thereof
11/18/2010US20100291138 Vaccine
11/18/2010US20100291134 Truncated hepatitis c virus ns5 domain and fusion proteins comprising same
11/18/2010US20100291133 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
11/18/2010US20100291132 Streptococcus uberis adhesion molecule
11/18/2010US20100291131 Clostridial toxin netb
11/18/2010US20100291127 Tumor associated antigen peptides and use of same as anti-tumor vaccines
11/18/2010US20100291126 Protein showing enhanced expression in cancer cells
11/18/2010US20100291125 Eta-1 gene and methods for use
11/18/2010US20100291121 Tumour-Specific Animal Proteins
11/18/2010US20100291120 Peptides regulating the surface expression of the t cell receptor
11/18/2010US20100291119 Alpha B crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
11/18/2010US20100291112 Recombinant, Single-Chain, Trivalent Tri-Specific or Bi-Specific Antibody Derivatives
11/18/2010US20100291109 Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunity
11/18/2010US20100291106 Compositions and methods for antibodies targeting complement protein c3b
11/18/2010US20100291104 Bordetella outer-membrane protein antigens and methods of making and using the same
11/18/2010US20100291095 Identification of a conserved region of plasmodium falciparum msp3 targeted by biologically active antibodies
11/18/2010US20100291091 Cancer associated gene ly6k
11/18/2010US20100291088 Il-18 binding proteins
11/18/2010US20100291086 Use of estrogen and androgen binding proteins in methods and compositions for treating gynaecological cancers
11/18/2010US20100291082 Antigen presenting cell targeted anti-viral vaccines
11/18/2010US20100291079 Heterodimeric Follicle Stimulating Hormone-Fc (FSH-Fc) Fusion Proteins for the Treatment of Infertility
11/18/2010US20100291078 Proteinaceous binding molecules comprising purification tags or inert variable domains
11/18/2010US20100291076 Antibodies specific for dkk-1 and their uses
11/18/2010US20100291075 Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Neutralizing Antibodies
11/18/2010US20100291072 Antibody variants with faster antigen association rates
11/18/2010US20100291061 Process for making oligopeptides
11/18/2010US20100291059 Pharmaceutical composition for enzyme replacement therapy
11/18/2010US20100291052 Novel Microorganism Having Gastric-Juice Promoting Activity, and Its Secretory Product
11/18/2010US20100291048 Modification of CXCR4 using engineered zinc finger proteins
11/18/2010US20100291043 Il-12 immunotherapy for cancer
11/18/2010US20100291040 Virus-like particles for treatment of viral infections
11/18/2010US20100291037 Immunogenicity using a combination of dna and vaccinia virus vector vaccines
11/18/2010US20100291036 Compositions and methods for modulating vascular endothelial growth factor c (vegf-c) expression
11/18/2010US20100290993 Antibodies to IL-6 and use thereof
11/18/2010DE102009021592A1 ASLV-Vektorsystem ASLV-vector system
11/18/2010CA2766676A1 Aslv vector system
11/18/2010CA2762108A1 Methods and compositions relating to fusions of alk for diagnosing and treating cancer
11/18/2010CA2761924A1 Menigococcus vaccine containing lipooligosaccharide (los) from modified strains of l6 immunotype neisseria meningitidis
11/18/2010CA2761856A1 Use of the gtpase rab27b to diagnose and treat poor prognosis estrogen-receptor-positive breast cancer
11/18/2010CA2761800A1 Anti-human cd52 immunoglobulins
11/18/2010CA2761749A1 Sirna conjugate and preparation method thereof
11/18/2010CA2761622A1 Dna sequences encoding caryophyllaceae and caryophyllaceae-like cyclopeptide precursors and methods of use
11/18/2010CA2761578A1 Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein
11/18/2010CA2761533A1 Plant promoter operable in basal endosperm transfer layer of endosperm and uses thereof
1 ... 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 ... 4023